Similar Papers

Paper Title
Journal
Date
Author
Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience
Maryam Barkhordar ... Mohammad Vaezi
Leukemia Research | VOL. 120
Maryam Barkhordar, et. al.Maryam Barkhordar ... Mohammad Vaezi
12 Jul 2022
KIR- Ligand Mismatching Is Associated with Inferior Survival in Patients with Acute Leukemia Following T-Cell Replete Peripheral-Blood Stem Cell Haplo-Identical Transplantation with Post-Transplant Cyclophosphamide. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Avichai Shimoni ... Arnon Nagler
Blood | VOL. 130
Avichai Shimoni, et. al.Avichai Shimoni ... Arnon Nagler
25 Jun 2021
Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Identical Peripheral Blood Hematopoietic Stem Cell Transplantation
Hang Zhang ... Jie Ji
Blood | VOL. 142
Hang Zhang, et. al.Hang Zhang ... Jie Ji
02 Nov 2023
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Giorgia Battipaglia ... Mohamad Mohty
Transplantation and Cellular Therapy | VOL. 28
Giorgia Battipaglia, et. al.Giorgia Battipaglia ... Mohamad Mohty
14 Jun 2022
View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title
Journal
Date
Author
Editorial Board
-
Clinical Lymphoma Myeloma and Leukemia | VOL. -
--
01 Feb 2025
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression
Mohammad Ma'Koseh ... Hikmat Abdel-Razeq
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Mohammad Ma'Koseh, et. al.Mohammad Ma'Koseh ... Hikmat Abdel-Razeq
01 Feb 2025
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia with Azacitidine plus Venetoclax
Joseph Brandwein ... Peng Wang
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Joseph Brandwein, et. al.Joseph Brandwein ... Peng Wang
01 Feb 2025
mRNA expression in DLBCL patients who are CD20 dim with an eye towards more thoughtful design of R/R trials, possibly incorporating BCMA Bite therapy
Bruce Hough ... Maher Albitar
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Bruce Hough, et. al.Bruce Hough ... Maher Albitar
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.